Re: docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.
作者信息
Taneja Samir S
出版信息
J Urol. 2014 Mar;191(3):656. doi: 10.1016/j.juro.2013.11.085. Epub 2013 Nov 28.
PMID:24522033
Abstract
摘要
Zotero 插件